| dc.creator |
Ozen, ME |
|
| dc.creator |
Savas, HA |
|
| dc.creator |
Tutkun, H |
|
| dc.creator |
Yilmaz, HR |
|
| dc.creator |
Akyol, O |
|
| dc.creator |
Herken, H |
|
| dc.creator |
Kalenderoglu, A |
|
| dc.creator |
Gulec, M |
|
| dc.date |
2006-01-01T01:00:00Z |
|
| dc.date.accessioned |
2021-12-03T11:20:34Z |
|
| dc.date.available |
2021-12-03T11:20:34Z |
|
| dc.identifier |
3ecf00ba-7793-4e01-b3d1-84346903b93e |
|
| dc.identifier |
10.1002/hup.742 |
|
| dc.identifier |
https://avesis.sdu.edu.tr/publication/details/3ecf00ba-7793-4e01-b3d1-84346903b93e/oai |
|
| dc.identifier.uri |
http://acikerisim.sdu.edu.tr/xmlui/handle/123456789/91082 |
|
| dc.description |
Objective In the present study, we aimed to investigate whether nitric oxide (NO) levels and activities of xanthine oxidase (XO), superoxide dismutase (SOD), and adenosine deaminase (ADA) are associated with Panic disorder (PD) as well as impact of psychopharmacological treatments on NO, SOD, ADA, and XO levels in PD. |
|
| dc.language |
eng |
|
| dc.rights |
info:eu-repo/semantics/closedAccess |
|
| dc.title |
Nitric oxide, adenosine deaminase, xanthine oxidase and superoxide dismutase in patients with panic disorder: alterations by antidepressant treatment |
|
| dc.type |
info:eu-repo/semantics/article |
|